Back to StakeholdersVisit Provider
Categories
2 domains / 4 areas / 2 specializations
NYU Langone Health
Data updated
United States
11 Trials
Home to the NYU Langone Center for Psychedelic Medicine, one of the world's leading academic institutions in psychedelic research. Has conducted landmark psilocybin trials for smoking cessation, alcohol use disorder, and depression in cancer patients, spearheaded by Dr. Michael Bogenschutz and colleagues.
Academic Research
0 papersPublished Papers
0
Trial Involvement
11
Distinct Focus Topics
0
Latest Publication
Unknown
Clinical Care Delivery Snapshot
Health Systems & HospitalsProvider Model
Health System / Hospital Program
Organization Status
Unknown
Psychedelic Services
Unknown
Service Coverage
Global
Service Profile
Care Settings
Hospital Outpatient
Payer Models
Unknown
Non-Psychedelic Service Mix
Unknown
Care Delivery Notes
Backfilled profile for existing L2 clinical care delivery stakeholder.
Quick Facts
- Type
- Other
- HQ
- United States
- Website
- Visit